ConvaTec Group PLC (CTEC) - Total Liabilities

Latest as of June 2025: GBX1.96 Billion GBX ≈ $238.51K USD

Based on the latest financial reports, ConvaTec Group PLC (CTEC) has total liabilities worth GBX1.96 Billion GBX (≈ $238.51K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CTEC cash flow metrics to assess how effectively this company generates cash.

ConvaTec Group PLC - Total Liabilities Trend (2009–2024)

This chart illustrates how ConvaTec Group PLC's total liabilities have evolved over time, based on quarterly financial data. Check ConvaTec Group PLC liquidity resilience to evaluate the company's liquid asset resilience ratio.

ConvaTec Group PLC Competitors by Total Liabilities

The table below lists competitors of ConvaTec Group PLC ranked by their total liabilities.

Company Country Total Liabilities
Seowon
KO:021050
Korea ₩670.18 Billion
Indopoly Swakarsa Industry Tbk
JK:IPOL
Indonesia Rp198.53 Million
Tadmax Resources Berhad
KLSE:4022
Malaysia RM548.86 Million
InkTec Co. Ltd
KQ:049550
Korea ₩85.01 Billion
Aton Resources Inc
V:AAN
Canada CA$22.51 Million
Opticis Company Limited
KQ:109080
Korea ₩5.86 Billion
Nanoform Finland Plc
HE:NANOFH
Finland €12.56 Million

Liability Composition Analysis (2009–2024)

This chart breaks down ConvaTec Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is ConvaTec Group PLC worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.95 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.52 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ConvaTec Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ConvaTec Group PLC (2009–2024)

The table below shows the annual total liabilities of ConvaTec Group PLC from 2009 to 2024.

Year Total Liabilities Change
2024-12-31 GBX1.83 Billion
≈ $222.18K
-9.64%
2023-12-31 GBX2.02 Billion
≈ $245.90K
+1.95%
2022-12-31 GBX1.98 Billion
≈ $241.19K
+0.16%
2021-12-31 GBX1.98 Billion
≈ $240.81K
-5.56%
2020-12-31 GBX2.10 Billion
≈ $255.00K
+2.29%
2019-12-31 GBX2.05 Billion
≈ $249.28K
+0.27%
2018-12-31 GBX2.04 Billion
≈ $248.60K
-10.27%
2017-12-31 GBX2.28 Billion
≈ $277.06K
+0.41%
2016-12-31 GBX2.27 Billion
≈ $275.91K
-43.45%
2015-12-31 GBX4.01 Billion
≈ $487.93K
-34.66%
2014-12-31 GBX6.14 Billion
≈ $746.74K
-8.32%
2013-12-31 GBX6.69 Billion
≈ $814.50K
+5.39%
2012-12-31 GBX6.35 Billion
≈ $772.85K
+10.69%
2011-12-31 GBX5.74 Billion
≈ $698.20K
+1.64%
2010-12-31 GBX5.65 Billion
≈ $686.95K
-0.55%
2009-12-31 GBX5.68 Billion
≈ $690.76K
--

About ConvaTec Group PLC

LSE:CTEC UK Medical Instruments & Supplies
Market Cap
$49.81 Million
GBX409.38 Billion GBX
Market Cap Rank
#21897 Global
#153 in UK
Share Price
GBX210.00
Change (1 day)
-0.38%
52-Week Range
GBX210.00 - GBX295.40
All Time High
GBX295.40
About

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostom… Read more